Delivery Order SPE2DB22D2007-SPE2DB24FJ4FL
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,078.28 firm fixed-price delivery order is for the supply of QSYMIA 11.25 MG-69 MG capsules. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $6,070.08, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of 4564800154 QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,708.20, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of the pharmaceutical product QSYMIA 3.75MG-23MG 30S. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $3,153.36, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of a specific pharmaceutical product, QSYMIA 3.75 MG-23 MG capsules, with an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,026.99 firm fixed price delivery order is for the supply of QSYMIA 3.75 MG-23 MG capsules, a prescription medication. The award is a task order under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole prime contractor. This IDC...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award, valued at $1,525.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of the pharmaceutical product QSYMIA 15 MG-92 MG CAPSULE 30S. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. It is not designated as a set-aside...